Category Archives: Updates
Supreme Court to decide on women’s right to dance in bars
9 May 2013, New Delhi: The Supreme Court today reserved its decision on the constitutionality of the ban on dance performances in bars in Maharashtra imposed under the Bombay Police (Amendment) Act of 2005. Introduced in August 2005, section 33A
Attack on affordable medicines continues in EU-India trade negotiations
Attack on affordable medicines continues in EU-India trade negotiations Health groups rally in Delhi as protests spread across the developing world 10 April, 2013, New Delhi- Thousands of people living with HIV, cancer patient groups & public health activists rallied
Apex court right to reject Novartis’s attempt
Novartis threat that it would not introduce new medicines in India after the verdict is hollow, says Anand Grover. While the patients and the generic companies have rejoiced over the Supreme Court’s verdict in the Novartis case rejecting the patent
NDTV programme: Mr. Anand Grover speaking on the Novartis judgment
Mr. Anand Grover speaking on the Novartis judgment View the video
South Korean civil society groups welcome the ruling of the Supreme Court of India
[Novartis defeated in its appeal trial, a triumphant victory of World patients fighting back Patent Exclusivity] Welcome the ruling of the Supreme Court of India 1. The protracted Novartis’ appeal from 2006 for a patent to Gleevec (Leukemia medicine), and
Strictest patent laws will foster genuine innovation
In 2005, as the Indian Parliament debated at length the impact of complying with the WTO’s TRIPS Agreement, one issue was uppermost in their minds; the impact of granting patents on access to affordable generic medicines. And, the one medicine
Glivec ruling: Putting patients before profits
Supreme Court’s verdict on Glivec benefits not just millions in India, but across the developing world Anand Grover Novartis’s assertions that the ruling will affect investment or future innovations have been belied time and again, including at the World Health
Supreme Court Rejects Novartis Appeal; Upholds high standard for Section 3(d)
Supreme Court Rejects Novartis’ Appeal; Upholds high standard for Section 3(d) 1 April 2013, New Delhi.— In a triumphant victory for patients fighting for access to medicines, a division bench of the Supreme Court of India comprising Hon’ble Justice Aftab
